CRUCIAL INNOVATIONS CORP.

4.55

0.0000

Volume:- -

Turnover:- -

Market Cap:338.60M

PE:-3.65K

High:4.55

Open:4.55

Low:4.55

Close:4.55

52wk High:4.55

52wk Low:4.55

Shares:74.42M

Float Shares:10.85M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0012

EPS(LYR):-0.0007

ROE:168.41%

ROA:-77.61%

PB:-6165.62

PE(LYR):-6,537.36

Loading ...

Overview Company News Filings

Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance

GlobeNewswire

·

May 11

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CINV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CINV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CINV\",,,,,undefined,":{"symbol":"CINV","market":"US","secType":"STK","nameCN":"CRUCIAL INNOVATIONS CORP.","latestPrice":4.55,"timestamp":1779898320000,"preClose":4.55,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":10853468,"shares":74417002,"eps":-0.001246,"marketStatus":"Trading","change":0,"latestTime":"05-27 12:12:00 EDT Delay","open":4.55,"high":4.55,"low":4.55,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.001246,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1779912000000},"marketStatusCode":2,"adr":0,"exchange":"EXPERT","adjPreClose":4.55,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CINV\",,,,,undefined,":{"symbol":"CINV","floatShares":10853468,"roa":"-77.61%","roe":"168.41%","lyrEps":-0.000696,"shares":74417002,"dividePrice":0,"high":4.55,"amplitude":0,"preClose":4.55,"low":4.55,"week52Low":4.55,"pbRate":"-6165.62","week52High":4.55,"institutionHeld":0,"latestPrice":4.55,"eps":-0.001246,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.001246,"open":4.55,"prevYearClose":4.55,"prevWeekClose":4.55,"prevMonthClose":4.55,"prevQuarterClose":4.55,"fiveDayClose":4.55,"twentyDayClose":4.55,"sixtyDayClose":4.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CINV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-30","symbol":"CINV","reason":null,"defaultRemindTime":1717075800000,"announcedDate":"2024-05-29","type":"delisting","dateTimestamp":1717041600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CINV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CINV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CINV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2634404286","title":"Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2634404286","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634404286?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:00","pubTimestamp":1778500800,"startTime":"0","endTime":"0","summary":"Q1 2026 net revenue growth year-over year for Acute Care franchise (+32%), including ZYNRELEF (+27%) and APONVIE (+50%)Q1 2026 total net revenue of $34.7 millionReached settlement with Baxter Healthca","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3291812/0/en/Heron-Therapeutics-Announces-First-Quarter-2026-Financial-Results-and-Reaffirms-Guidance.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","BK4161","BK4195","MEC","CINV","HRTX","RA","PFS","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}